Non-Myeloablative Allogeneic Transplantation

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Surgery
Cover of the book Non-Myeloablative Allogeneic Transplantation by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461509196
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461509196
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

More books from Springer US

Cover of the book Blastomycosis by
Cover of the book Pricing and Regulatory Innovations Under Increasing Competition by
Cover of the book New Directions in Failure to Thrive by
Cover of the book Health Research in Practice by
Cover of the book Biochemistry of Scandium and Yttrium, Part 1: Physical and Chemical Fundamentals by
Cover of the book Instruction Level Parallelism by
Cover of the book Nonverbal Communication of Aggression by
Cover of the book EMI/EMC Computational Modeling Handbook by
Cover of the book The Tunnel Effect in Chemistry by
Cover of the book Environmental Systems Engineering by
Cover of the book Neuropsychological Evaluation of the Spanish Speaker by
Cover of the book Soft Errors in Modern Electronic Systems by
Cover of the book Dictionary of Global Climate Change by
Cover of the book Cancer Neutron Capture Therapy by
Cover of the book Radioecological Techniques by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy